vs
Side-by-side financial comparison of Incyte (INCY) and UPBOUND GROUP, INC. (UPBD). Click either name above to swap in a different company.
Incyte is the larger business by last-quarter revenue ($1.3B vs $1.2B, roughly 1.1× UPBOUND GROUP, INC.). Incyte runs the higher net margin — 23.8% vs 1.7%, a 22.2% gap on every dollar of revenue. On growth, Incyte posted the faster year-over-year revenue change (20.9% vs 10.9%). Over the past eight quarters, Incyte's revenue compounded faster (10.4% CAGR vs 4.5%).
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Upbound Group, Inc. is a leading US provider of flexible lease-to-own solutions for consumer goods. It offers furniture, consumer electronics, home appliances, and accessories, catering to customers seeking accessible payment alternatives to traditional retail financing.
INCY vs UPBD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.2B |
| Net Profit | $303.3M | $19.7M |
| Gross Margin | — | 49.0% |
| Operating Margin | 23.7% | 4.8% |
| Net Margin | 23.8% | 1.7% |
| Revenue YoY | 20.9% | 10.9% |
| Net Profit YoY | 91.7% | -36.3% |
| EPS (diluted) | $1.47 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.5B | $1.2B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.2B | $1.1B | ||
| Q3 24 | $1.1B | $1.1B | ||
| Q2 24 | $1.0B | $1.1B |
| Q1 26 | $303.3M | — | ||
| Q4 25 | $299.3M | $19.7M | ||
| Q3 25 | $424.2M | $13.2M | ||
| Q2 25 | $405.0M | $15.5M | ||
| Q1 25 | $158.2M | $24.8M | ||
| Q4 24 | $201.2M | $31.0M | ||
| Q3 24 | $106.5M | $30.9M | ||
| Q2 24 | $-444.6M | $33.9M |
| Q1 26 | — | — | ||
| Q4 25 | 92.0% | 49.0% | ||
| Q3 25 | 92.8% | 48.3% | ||
| Q2 25 | 93.5% | 49.4% | ||
| Q1 25 | 93.0% | 46.8% | ||
| Q4 24 | 92.5% | 47.1% | ||
| Q3 24 | 92.4% | 47.8% | ||
| Q2 24 | 92.7% | 49.4% |
| Q1 26 | 23.7% | — | ||
| Q4 25 | 22.3% | 4.8% | ||
| Q3 25 | 32.5% | 4.5% | ||
| Q2 25 | 43.6% | 4.4% | ||
| Q1 25 | 19.5% | 5.3% | ||
| Q4 24 | 25.6% | 7.3% | ||
| Q3 24 | 12.8% | 6.6% | ||
| Q2 24 | -45.8% | 7.5% |
| Q1 26 | 23.8% | — | ||
| Q4 25 | 19.9% | 1.7% | ||
| Q3 25 | 31.1% | 1.1% | ||
| Q2 25 | 33.3% | 1.3% | ||
| Q1 25 | 15.0% | 2.1% | ||
| Q4 24 | 17.1% | 2.9% | ||
| Q3 24 | 9.4% | 2.9% | ||
| Q2 24 | -42.6% | 3.2% |
| Q1 26 | $1.47 | — | ||
| Q4 25 | $1.46 | $0.35 | ||
| Q3 25 | $2.11 | $0.22 | ||
| Q2 25 | $2.04 | $0.26 | ||
| Q1 25 | $0.80 | $0.42 | ||
| Q4 24 | $0.90 | $0.55 | ||
| Q3 24 | $0.54 | $0.55 | ||
| Q2 24 | $-2.04 | $0.61 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $120.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $5.6B | $695.7M |
| Total Assets | $7.3B | $3.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.1B | $120.5M | ||
| Q3 25 | $2.5B | $107.0M | ||
| Q2 25 | $2.0B | $106.8M | ||
| Q1 25 | $1.9B | $107.3M | ||
| Q4 24 | $1.7B | $60.9M | ||
| Q3 24 | $1.3B | $85.1M | ||
| Q2 24 | $987.3M | $82.5M |
| Q1 26 | $5.6B | — | ||
| Q4 25 | $5.2B | $695.7M | ||
| Q3 25 | $4.7B | $687.3M | ||
| Q2 25 | $4.2B | $685.5M | ||
| Q1 25 | $3.7B | $679.2M | ||
| Q4 24 | $3.4B | $629.0M | ||
| Q3 24 | $3.2B | $611.8M | ||
| Q2 24 | $3.0B | $596.3M |
| Q1 26 | $7.3B | — | ||
| Q4 25 | $7.0B | $3.3B | ||
| Q3 25 | $6.3B | $3.2B | ||
| Q2 25 | $5.8B | $3.1B | ||
| Q1 25 | $5.7B | $3.0B | ||
| Q4 24 | $5.4B | $2.6B | ||
| Q3 24 | $5.0B | $2.6B | ||
| Q2 24 | $4.7B | $2.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $41.6M |
| Free Cash FlowOCF − Capex | — | $24.0M |
| FCF MarginFCF / Revenue | — | 2.0% |
| Capex IntensityCapex / Revenue | — | 1.5% |
| Cash ConversionOCF / Net Profit | — | 2.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $238.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $543.3M | $41.6M | ||
| Q3 25 | $559.4M | $118.4M | ||
| Q2 25 | $44.7M | $7.8M | ||
| Q1 25 | $266.1M | $137.7M | ||
| Q4 24 | $381.2M | $-61.9M | ||
| Q3 24 | $310.9M | $106.2M | ||
| Q2 24 | $-575.6M | $15.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $24.0M | ||
| Q3 25 | — | $97.9M | ||
| Q2 25 | — | $-10.4M | ||
| Q1 25 | — | $127.2M | ||
| Q4 24 | — | $-74.0M | ||
| Q3 24 | — | $88.3M | ||
| Q2 24 | — | $613.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 8.4% | ||
| Q2 25 | — | -0.9% | ||
| Q1 25 | — | 10.8% | ||
| Q4 24 | — | -6.9% | ||
| Q3 24 | — | 8.3% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.5% | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | 2.11× | ||
| Q3 25 | 1.32× | 8.96× | ||
| Q2 25 | 0.11× | 0.50× | ||
| Q1 25 | 1.68× | 5.56× | ||
| Q4 24 | 1.89× | -2.00× | ||
| Q3 24 | 2.92× | 3.44× | ||
| Q2 24 | — | 0.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
